MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 18, 2007; DOI: 10.1124/mol.107.039792


0026-895X/07/7206-1545-1556$20.00
Mol Pharmacol 72:1545-1556, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.039792v1
72/6/1545    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aires, V.
Right arrow Articles by Khan, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aires, V.
Right arrow Articles by Khan, N. A.

Docosahexaenoic Acid Induces Increases in [Ca2+]i via Inositol 1,4,5-Triphosphate Production and Activates Protein Kinase C{gamma} and -{delta} via Phosphatidylserine Binding Site: Implication in Apoptosis in U937 Cells

Virginie Aires, Aziz Hichami, Rodolphe Filomenko, Aude Plé, Cédric Rébé, Ali Bettaieb, and Naim Akhtar Khan

Unité Propre de Recherche et de l'Enseignement Supérieur, Equipe d'Accueil 4183–Lipides & Signalisation Cellulaire, Faculty of Life Sciences, University of Burgundy, Dijon, France (V.A., A.H., A.P., N.A.K.); and Institut National de la Santé etdela Recherche Médicale U866, Ecole Pratique des Hautes Etudes, University of Burgundy, Dijon, France (R.F., C.R., A.B.)

We investigated, in monocytic leukemia U937 cells, the effects of docosahexaenoic acid (DHA; 22:6 n-3) on calcium signaling and determined the implication of phospholipase C (PLC) and protein kinase C (PKC) in this pathway. DHA induced dose-dependent increases in [Ca2+]i, which were contributed by intracellular pool, via the production of inositol-1,4,5-triphosphate (IP3) and store-operated Ca2+ (SOC) influx, via opening of Ca2+ release-activated Ca2+ (CRAC) channels. Chemical inhibition of PLC, PKC{gamma}, and PKC{delta}, but not of PKCbeta I/II, PKC{alpha}, or PKCbetaI, significantly diminished DHA-induced increases in [Ca2+]i. In vitro PKC assays revealed that DHA induced a ~2-fold increase in PKC{gamma} and -{delta} activities, which were temporally correlated with the DHA-induced increases in [Ca2+]i. In cell-free assays, DHA, but not other structural analogs of fatty acids, activated these PKC isoforms. Competition experiments revealed that DHA-induced activation of both the PKCs was dose-dependently inhibited by phosphatidylserine (PS). Furthermore, DHA induced apoptosis via reactive oxygen species (ROS) production, followed by caspase-3 activation. Chemical inhibition of PKC{gamma}/{delta} and of SOC/CRAC channels significantly attenuated both DHA-stimulated ROS production and caspase-3 activity. Our study suggests that DHA-induced activation of PLC/IP3 pathway and activation of PKC{gamma}/{delta}, via its action on PS binding site, may be involved in apoptosis in U937 cells.


Received July 9, 2007; accepted September 17, 2007

Address correspondence to: N. A. Khan, Directeur, UPRES EA4183 Lipids and Signalisation Cellulaire, Université de Bourgogne, Faculté des Sciences de la Vie, 6 Bd Gabriel, 21000 Dijon, France. E-mail: naim.khan{at}u-bourgogne.fr







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics